"Le CHU de Rouen, au cœur du Campus Santé Rouen Normandie, contribue au développement d’un véritable écosystème dédié à la santé. Ses 10 300 professionnels sont au service d'une triple mission : soigner et prendre soin de chaque patient, former les futurs médecins et soignants et faire avancer la recherche au bénéfice de tous. Avec ses 5 établissements de soins et d'hébergement, le CHU de Rouen est l’établissement support du Groupement hospitalier de territoire (GHT) Rouen Cœur de Seine. Premier employeur de Normandie, il se positionne parmi les 12 plus importants CHU français en termes d’activités."

During the past decade, Clinique Pneumologique; Hôpital Charles Nicolle conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Pneumologique; Hôpital Charles Nicolle" #1 collaborator was "Groupe Francais De Pneumo-Cancerologie" with 1 trials as a collaborator, "Groupe Français de Pneumologie Cancérologie (GFPC)" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Pneumologique; Hôpital Charles Nicolle" are "Carcinoma, Non-Small-Cell Lung" (1 trials), "Non Small Cell Lung Cancer" (1 trials) and "Non Small Cell Lung Carcinoma" (1 trials). Many other conditions were trialed in "Clinique Pneumologique; Hôpital Charles Nicolle" in a lesser frequency.

Most popular intervention types in "Clinique Pneumologique; Hôpital Charles Nicolle" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Alimta®" (1 trials), "Docetaxel" (1 trials), "Erlotinib + docetaxel" (1 trials), "Gemcitabine" (1 trials) and "Taxol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Pneumologique; Hôpital Charles Nicolle" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Clinique Pneumologique; Hôpital Charles Nicolle". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Clinique Pneumologique; Hôpital Charles Nicolle, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Pneumologique; Hôpital Charles Nicolle, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".